The Middle East and Africa poultry probiotic ingredients market is expected to reach USD 88,346.43 thousand by 2030 from USD 61,730.85 thousand in 2022, growing at a CAGR of 4.7% during the forecast period of 2023 to 2030.
Market Segmentation:
Middle East and Africa Poultry Probiotic Ingredients Market, By Product (Bacteria based and Fungi and Yeast Based), Type (Single Strain and Multiple Strain), Form (Dry and Liquid), Function (Feed Intake and Efficiency, Yield, Gut Health, Nutrition, Egg Production & Quality Immunity and Others), Application (Broilers, Layers, Breeders, Chicks & Poults, and Others), Country (South Africa, Saudi Arabia, UAE, Kuwait, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2030
Overview of Middle East and Africa Poultry Probiotic Ingredients Market Dynamics:
Driver
Increasing awareness of the benefits of plant-based products
Restrain
Inadequate raw material availability
Opportunity
Growing commercial application of probiotics in poultry products
Market Players:
Some of the major market players operating in the Middle East and Africa poultry probiotic ingredients market are:
Lallemand Inc
Alltech
Biocamp
International Animal Health Products
Unique Biotech
Provita Animal Health
Phileo by Lesaffre
Novozymes
Evonik Industries AG
ASAHI GROUP HOLDINGS, LTD
Chr. Hansen Holding A/S
Advanced Enzyme Technologies
International Flavors & Fragrances Inc
Kemin Industries, Inc
PANGOO
TABLE OF CONTENTS
1 INTRODUCTION 42
1.1 OBJECTIVES OF THE STUDY 42
1.2 MARKET DEFINITION 42
1.3 OVERVIEW OF MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET 42
1.4 LIMITATIONS 44
1.5 MARKETS COVERED 44
2 MARKET SEGMENTATION 47
2.1 MARKETS COVERED 47
2.2 GEOGRAPHICAL SCOPE 48
2.3 YEARS CONSIDERED FOR THE STUDY 49
2.4 CURRENCY AND PRICING 49
2.5 DBMR TRIPOD DATA VALIDATION MODEL 50
2.6 MULTIVARIATE MODELLING 53
2.7 PRODUCT LIFELINE CURVE 53
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 54
2.9 DBMR MARKET POSITION GRID 55
2.10 MARKET END USERS COVERAGE GRID 56
2.11 VENDOR SHARE ANALYSIS 57
2.12 SECONDARY SOURCES 58
2.13 ASSUMPTIONS 58
3 EXECUTIVE SUMMARY 59
4 PREMIUM INSIGHTS 61
4.1 VALUE CHAIN ANALYSIS 62
4.2 SUPPLY CHAIN ANALYSIS 63
4.2.1 RAW MATERIAL PROCUREMENT 63
4.2.2 MANUFACTURING AND DISTRIBUTION 63
4.2.3 END USERS 63
4.3 PORTER'S FIVE FORCES 64
4.3.1 BARGAINING POWER OF SUPPLIERS 64
4.3.2 BARGAINING POWER OF BUYERS/CONSUMERS 64
4.3.3 THREAT OF NEW ENTRANTS 65
4.3.4 THREAT OF SUBSTITUTES PRODUCTS 65
4.3.5 INTENSITY OF COMPETITIVE RIVALRY 65
4.4 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 66
4.5 OVERVIEW OF TECHNOLOGICAL INNOVATIONS 67
4.6 INDUSTRY TRENDS AND FUTURE PERSPECTIVE 68
4.7 FACTORS INFLUENCING PURCHASING DECISION OF END-USERS 69
5 PRICING ANALYSIS 70
6 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET, REGULATIONS 71
7 MARKET OVERVIEW, MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET 73
7.1 DRIVERS 75
7.1.1 GROWING PRODUCTION OF FEED ADDITIVES 75
7.1.2 INCREASING AWARENESS OF THE BENEFITS OF PLANT-BASED PRODUCTS 75
7.1.3 INCREASED DEMAND AND CONSUMPTION OF LIVESTOCK-BASED PRODUCTS 76
7.2 RESTRAINTS 76
7.2.1 STRICT RESTRICTIONS AND REGULATIONS IMPOSED BY GOVERNMENT 76
7.2.2 INADEQUATE RAW MATERIAL AVAILABILITY 77
7.3 OPPORTUNITIES 77
7.3.1 GROWING COMMERCIAL APPLICATION 77
7.3.2 RISING RESEARCH AND DEVELOPMENT ACTIVITIES 77
7.4 CHALLENGES 78
7.4.1 AVAILABILITY OF FEED ADDITIVE SUBSTITUTES 78
7.4.2 PRODUCT LABELLING AND TRADE ISSUES 78
8 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY PRODUCT 79
8.1 OVERVIEW 80
8.1.1 BACTERIA BASED 83
8.1.1.1 BACILLUS 84
8.1.1.1.1 SUBTILIS 85
8.1.1.1.2 LICHENIFORMIS 85
8.1.1.1.3 AMYLOLIQUEFACIENS 85
8.1.1.1.4 MEGATERIUM 85
8.1.1.1.5 MESENTRICUS 85
8.1.1.1.6 POLYMYXA 85
8.1.1.1.7 TOYONENSIS 85
8.1.1.1.8 OTHERS 85
8.1.1.2 LACTOBACILLUS 86
8.1.1.2.1 ACIDOPHILUS 86
8.1.1.2.2 BULGARICUS 86
8.1.1.2.3 REUTERI 86
8.1.1.2.4 CASEI 87
8.1.1.2.5 LACTIS 87
8.1.1.2.6 SALIVARIUS 87
8.1.1.2.7 PLANTARUM 87
8.1.1.2.8 RHAMNOSUS 87
8.1.1.2.9 FERMENTUM 87
8.1.1.2.10 FARCIMINIS 87
8.1.1.2.11 THERMOPHILUS 87
8.1.1.2.12 OTHERS 88
8.1.1.3 BIFIDOBACTERIUM 88
8.1.1.3.1 BIFIDIUM 88
8.1.1.3.2 BIFIDUS 88
8.1.1.3.3 THERMOPHILUS 88
8.1.1.3.4 ANIMALS 88
8.1.1.3.5 OTHERS 89
8.1.1.4 ENTEROCOCCUS 89
8.1.1.5 STREPTOCOCCUS 89
8.1.1.6 CLOSTRIDIUM 89
8.1.1.7 PEDIOCOCCUS 89
8.1.1.7.1 PARVULUS 89
8.1.1.7.2 ACIDILACTICI 89
8.1.1.7.3 OTHERS 90
8.1.2 FUNGI AND YEAST BASED 90
8.1.2.1 SACCHAROMYCES CEREVISIAE 91
8.1.2.2 SACCHAROMYCES BOULARDII 91
8.1.2.3 SACCHAROMYCES SERVISIA 91
8.1.2.4 CANDIDA 91
9 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY TYPE 92
9.1 OVERVIEW 93
9.1.1 SINGLE STRAIN 96
9.1.2 MULTIPLE STRAIN 96
10 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY FORM 98
10.1 OVERVIEW 99
10.1.1 DRY 102
10.1.2 LIQUID 102
11 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY FUNCTION 104
11.1 OVERVIEW 105
11.1.1 GUT HEALTH 108
11.1.2 IMMUNITY 108
11.1.3 NUTRITION 109
11.1.4 FEED INTAKE AND EFFICIENCY 110
11.1.5 YIELD 110
11.1.6 EGG PRODUCTION AND QUALITY 111
11.1.7 OTHERS 112
12 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY APPLICATION 113
12.1 OVERVIEW 114
12.1.1 CHICKS AND POULTS 117
12.1.1.1 BACTERIA BASED 118
12.1.1.2 FUNGI AND YEAST BASED 118
12.1.2 BROILERS 118
12.1.2.1 BACTERIA BASED 119
12.1.2.2 FUNGI AND YEAST BASED 119
12.1.3 LAYERS 119
12.1.3.1 BACTERIA BASED 120
12.1.3.2 FUNGI AND YEAST BASED 120
12.1.4 BREEDERS 120
12.1.4.1 BACTERIA BASED 121
12.1.4.2 FUNGI AND YEAST BASED 121
12.1.5 OTHERS 121
13 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY REGION 122
13.1 MIDDLE EAST AND AFRICA 123
13.1.1 SOUTH AFRICA 134
13.1.2 SAUDI ARABIA 141
13.1.3 KUWAIT 148
13.1.4 U.A.E. 155
13.1.5 REST OF MIDDLE EAST AND AFRICA 161
14 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET: COMPANY LANDSCAPE 162
14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 162
15 SWOT ANALYSIS 163
16 COMPANY PROFILE 164
16.1 LALLEMAND INC 164
16.1.1 COMPANY SNAPSHOT 164
16.1.2 COMPANY SHARE ANALYSIS 164
16.1.3 PRODUCT PORTFOLIO 165
16.1.4 RECENT DEVELOPMENT 165
16.2 EVONIK INDUSTRIES AG 166
16.2.1 COMPANY SNAPSHOT 166
16.2.2 REVENUE ANALYSIS 166
16.2.3 COMPANY SHARE ANALYSIS 167
16.2.4 PRODUCT PORTFOLIO 167
16.2.5 RECENT DEVELOPMENT 167
16.3 ASAHI GROUP HOLDINGS, LTD 168
16.3.1 COMPANY SNAPSHOT 168
16.3.2 REVENUE ANALYSIS 168
16.3.3 COMPANY SHARE ANALYSIS 169
16.3.4 PRODUCT PORTFOLIO 169
16.3.5 RECENT DEVELOPMENT 169
16.4 INTERNATIONAL FLAVORS & FRAGRANCES INC 170
16.4.1 COMPANY SNAPSHOT 170
16.4.2 REVENUE ANALYSIS 170
16.4.3 COMPANY SHARE ANALYSIS 171
16.4.4 PRODUCT PORTFOLIO 171
16.4.5 RECENT DEVELOPMENT 171
16.5 PHILEO BY LESAFFRE 172
16.5.1 COMPANY SNAPSHOT 172
16.5.2 COMPANY SHARE ANALYSIS 172
16.5.3 PRODUCT PORTFOLIO 173
16.5.4 RECENT DEVELOPMENT 173
16.6 ADVANCED ENZYME TECHNOLOGIES 174
16.6.1 COMPANY SNAPSHOT 174
16.6.2 REVENUE ANALYSIS 174
16.6.3 PRODUCT PORTFOLIO 175
16.6.4 RECENT DEVELOPMENT 175
16.7 ALLTECH 176
16.7.1 COMPANY SNAPSHOT 176
16.7.2 PRODUCT PORTFOLIO 176
16.7.3 RECENT DEVELOPMENTS 176
16.8 BIOCAMP 177
16.8.1 COMPANY SNAPSHOT 177
16.8.2 PRODUCT PORTFOLIO 177
16.8.3 RECENT DEVELOPMENT 177
16.9 CHR. HANSEN HOLDING A/S 178
16.9.1 COMPANY SNAPSHOT 178
16.9.2 REVENUE ANALYSIS 178
16.9.3 PRODUCT PORTFOLIO 179
16.9.4 RECENT DEVELOPMENT 179
16.10 INTERNATIONAL ANIMAL HEALTH PRODUCTS 180
16.10.1 COMPANY SNAPSHOT 180
16.10.2 PRODUCT PORTFOLIO 180
16.10.3 RECENT DEVELOPMENT 180
16.11 KEMIN INDUSTRIES, INC 181
16.11.1 COMPANY SNAPSHOT 181
16.11.2 PRODUCT PORTFOLIO 181
16.11.3 RECENT DEVELOPMENT 181
16.12 NOVOZYMES 182
16.12.1 COMPANY SNAPSHOT 182
16.12.2 REVENUE ANALYSIS 182
16.12.3 PRODUCT PORTFOLIO 183
16.12.4 RECENT DEVELOPMENT 183
16.13 PANGOO 184
16.13.1 COMPANY SNAPSHOT 184
16.13.2 PRODUCT PORTFOLIO 184
16.13.3 RECENT DEVELOPMENT 184
16.14 PROVITA ANIMAL HEALTH 185
16.14.1 COMPANY SNAPSHOT 185
16.14.2 PRODUCT PORTFOLIO 185
16.14.3 RECENT DEVELOPMENT 185
16.15 UNIQUE BIOTECH 186
16.15.1 COMPANY SNAPSHOT 186
16.15.2 PRODUCT PORTFOLIO 186
16.15.3 RECENT DEVELOPMENT 186
17 QUESTIONNAIRE 187
18 RELATED REPORTS 190